50.56
price up icon0.86%   0.43
after-market Handel nachbörslich: 50.56
loading
Schlusskurs vom Vortag:
$50.13
Offen:
$50.05
24-Stunden-Volumen:
234.55K
Relative Volume:
0.55
Marktkapitalisierung:
$2.43B
Einnahmen:
$379.25M
Nettoeinkommen (Verlust:
$-77.34M
KGV:
-31.36
EPS:
-1.6122
Netto-Cashflow:
$-27.87M
1W Leistung:
-0.47%
1M Leistung:
+14.91%
6M Leistung:
+20.30%
1J Leistung:
+53.86%
1-Tages-Spanne:
Value
$49.39
$51.57
1-Wochen-Bereich:
Value
$49.39
$51.57
52-Wochen-Spanne:
Value
$32.47
$54.23

Mirum Pharmaceuticals Inc Stock (MIRM) Company Profile

Name
Firmenname
Mirum Pharmaceuticals Inc
Name
Telefon
650-667-4085
Name
Adresse
989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY
Name
Mitarbeiter
334
Name
Twitter
@mirumpharma
Name
Nächster Verdiensttermin
2024-11-04
Name
Neueste SEC-Einreichungen
Name
MIRM's Discussions on Twitter

Vergleichen Sie MIRM mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
MIRM
Mirum Pharmaceuticals Inc
50.56 2.43B 379.25M -77.34M -27.87M -1.6122
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
443.40 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
521.00 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
318.25 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.04 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
254.49 28.51B 3.81B -644.79M -669.77M -6.24

Mirum Pharmaceuticals Inc Stock (MIRM) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-19 Fortgesetzt H.C. Wainwright Buy
2024-04-17 Eingeleitet Stifel Buy
2023-12-18 Bestätigt H.C. Wainwright Buy
2023-11-20 Fortgesetzt JP Morgan Overweight
2023-11-13 Eingeleitet Morgan Stanley Overweight
2023-10-24 Eingeleitet Cantor Fitzgerald Overweight
2023-10-17 Fortgesetzt Evercore ISI Outperform
2023-09-20 Eingeleitet JMP Securities Mkt Outperform
2022-09-01 Eingeleitet Citigroup Buy
2021-09-20 Eingeleitet JP Morgan Overweight
2020-08-07 Hochstufung Raymond James Outperform → Strong Buy
2020-08-03 Eingeleitet H.C. Wainwright Buy
2020-07-31 Eingeleitet Piper Sandler Overweight
2020-06-25 Eingeleitet Robert W. Baird Outperform
2019-08-12 Eingeleitet Citigroup Buy
2019-08-12 Eingeleitet Evercore ISI Outperform
2019-08-12 Eingeleitet Guggenheim Buy
2019-08-12 Eingeleitet ROTH Capital Buy
2019-08-12 Eingeleitet Raymond James Outperform
Alle ansehen

Mirum Pharmaceuticals Inc Aktie (MIRM) Neueste Nachrichten

pulisher
Jun 17, 2025

Rhumbline Advisers Purchases 2,321 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World

Jun 17, 2025
pulisher
Jun 15, 2025

Where are the Opportunities in (MIRM) - news.stocktradersdaily.com

Jun 15, 2025
pulisher
Jun 14, 2025

Insider Sell: William Fairey Sells Shares of Mirum Pharmaceutica - GuruFocus

Jun 14, 2025
pulisher
Jun 12, 2025

High Growth Tech Stocks In The US Market - Yahoo Finance

Jun 12, 2025
pulisher
Jun 12, 2025

Cantor Fitzgerald Predicts MIRM FY2026 Earnings - Defense World

Jun 12, 2025
pulisher
Jun 10, 2025

Mirum Pharmaceuticals Expands Team with 10 New Hires, Grants $5.7M Stock Options Package - Stock Titan

Jun 10, 2025
pulisher
Jun 10, 2025

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo

Jun 10, 2025
pulisher
Jun 08, 2025

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

Why Is Mirum Pharmaceuticals (MIRM) Down 1.3% Since Last Earnings Report? - Yahoo Finance

Jun 06, 2025
pulisher
Jun 06, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $3.06 Million Stock Position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World

Jun 06, 2025
pulisher
Jun 04, 2025

Insider Sell: Saira Ramasastry Sells 8,203 Shares of Mirum Pharm - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Mirum Pharmaceuticals director sells shares totaling $377,843 - Investing.com Australia

Jun 04, 2025
pulisher
Jun 04, 2025

Insider Sell: Saira Ramasastry Sells 8,203 Shares of Mirum Pharmaceuticals Inc (MIRM) - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Mirum Pharmaceuticals director sells shares totaling $377,843 By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 03, 2025

(MIRM) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

Jun 03, 2025
pulisher
May 31, 2025

Mirum pharmaceuticals raises 2025 revenue guidance to $435M-$450M driven by robust growth - MSN

May 31, 2025
pulisher
May 30, 2025

Mirum Pharmaceuticals Holds 2025 Annual Stockholders Meeting - TipRanks

May 30, 2025
pulisher
May 30, 2025

Alagille Syndrome Treatment Market Detailed in New Research ReportMirum Pharmaceuticals, Albireo Pharma - openPR.com

May 30, 2025
pulisher
May 29, 2025

Two Sigma Investments LP Has $5.23 Million Stock Holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - MarketBeat

May 29, 2025
pulisher
May 28, 2025

Man Group plc Invests $289,000 in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World

May 28, 2025
pulisher
May 26, 2025

Mirum Pharmaceuticals’ SWOT analysis: rare disease stock shows growth potential By Investing.com - Investing.com South Africa

May 26, 2025
pulisher
May 26, 2025

Mirum Pharmaceuticals’ SWOT analysis: rare disease stock shows growth potential - Investing.com Nigeria

May 26, 2025
pulisher
May 26, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Cuts Stock Holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World

May 26, 2025
pulisher
May 23, 2025

When the Price of (MIRM) Talks, People Listen - news.stocktradersdaily.com

May 23, 2025
pulisher
May 22, 2025

Mirum Pharmaceuticals (MIRM) – Research Analysts’ Weekly Ratings Changes - Defense World

May 22, 2025
pulisher
May 22, 2025

What is HC Wainwright’s Estimate for MIRM Q2 Earnings? - Defense World

May 22, 2025
pulisher
May 21, 2025

Mirum Pharmaceuticals at RBC Conference: Strategic Growth Highlights - Investing.com

May 21, 2025
pulisher
May 20, 2025

Mirum Pharmaceuticals Appoints Doug Sheehy, JD, as Chief Legal Officer - citybiz

May 20, 2025
pulisher
May 20, 2025

Comerica Bank Reduces Stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World

May 20, 2025
pulisher
May 20, 2025

Mirum Pharmaceuticals (NASDAQ:MIRM) Given “Buy” Rating at HC Wainwright - Defense World

May 20, 2025
pulisher
May 19, 2025

Mirum Pharmaceuticals Names Doug Sheehy New Chief Legal Officer - Bloomberg Law News

May 19, 2025
pulisher
May 19, 2025

Mirum Pharmaceuticals (MIRM) Receives Buy Rating from HC Wainwri - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Mirum Pharmaceuticals (MIRM) Appoints New Chief Legal Officer | - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Mirum Pharmaceuticals (MIRM) Receives Buy Rating from HC Wainwright & Co. | MIRM Stock News - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Mirum Pharmaceuticals (MIRM) Receives Buy Rating with Promising Growth Potential | MIRM Stock News - GuruFocus

May 19, 2025
pulisher
May 17, 2025

Analysts Set Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Price Target at $60.64 - Defense World

May 17, 2025
pulisher
May 15, 2025

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Q1 2025 Earnings Call Transcript - MSN

May 15, 2025
pulisher
May 15, 2025

Northern Trust Corp Acquires 32,059 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World

May 15, 2025
pulisher
May 15, 2025

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Shares Sold by The Manufacturers Life Insurance Company - Defense World

May 15, 2025
pulisher
May 14, 2025

Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences - Business Wire

May 14, 2025
pulisher
May 13, 2025

Mirum Pharmaceuticals (MIRM) Maintains Strong Buy Rating with Ra - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Mirum Pharmaceuticals (MIRM) Gets Price Target Boost to $77 | MI - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Trend Tracker for (MIRM) - news.stocktradersdaily.com

May 13, 2025
pulisher
May 12, 2025

FY2025 EPS Estimates for MIRM Raised by Cantor Fitzgerald - Defense World

May 12, 2025
pulisher
May 12, 2025

Leerink Partnrs Brokers Increase Earnings Estimates for MIRM - Defense World

May 12, 2025
pulisher
May 11, 2025

JMP Securities Increases Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target to $76.00 - Defense World

May 11, 2025
pulisher
May 09, 2025

Mirum Pharmaceuticals (MIRM) Price Target Raised Following Stron - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Beyond The Numbers: 4 Analysts Discuss Mirum Pharmaceuticals Stock - Benzinga

May 09, 2025
pulisher
May 09, 2025

Mirum Pharmaceuticals (MIRM) Maintains Market Outperform Rating with Higher Price Target | MIRM Stock News - GuruFocus

May 09, 2025

Finanzdaten der Mirum Pharmaceuticals Inc-Aktie (MIRM)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.73
price up icon 1.02%
$35.27
price down icon 1.78%
$21.32
price up icon 0.24%
$101.74
price down icon 2.97%
$106.14
price up icon 1.28%
biotechnology ONC
$254.49
price down icon 4.73%
Kapitalisierung:     |  Volumen (24h):